Typical chest pain and normal coronary angiogram: Cardiac risk factor analysis versus PET for detection of microvascular disease

Journal of Nuclear Medicine

Volumn 48, Issue 2, 2007, Pages 175-181

  Graf, Senta ^a   Khorsand, Aliasghar ^a   Gwechenberger, Marianne ^a   Novotny, Clemens ^a   Kletter, Kurt ^a   Sochor, Heinz ^a   Pirich, Christian ^b   Maurer, Gerald ^a   Porenta, Gerold ^c   Zehetgruber, Manfred ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

^c Rudolfinerhaus ^*  (Austria)

Author keywords

Cardiac risk factors; Coronary flow reserve; Microvascular disease; PET

Indexed keywords

AMMONIA; DIPYRIDAMOLE; NITROGEN 13; LIPID;

ADULT; AGE; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EPICARDIUM; FACTORIAL ANALYSIS; FEMALE; HEART VENTRICLE SEPTUM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROANGIOPATHY; MICROCIRCULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; IMAGE PROCESSING; MIDDLE AGED; PHYSIOLOGY; ROC CURVE; SCINTISCANNING; SYNDROME X;

ADULT; AGED; BLOOD PRESSURE; CHEST PAIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPIDS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; ROC CURVE;

EID: 34047227156     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Proudfit WL, Shirey EK, Sones FM Jr. Selective cine coronary arteriography: correlation with clinical findings in 1,000 patients. Circulation. 1966;33:901-910.
2. Mahrer PR, Eshoo N. Outpatient cardiac catheterization and coronary angiography. Cathet Cardiovasc Diagn. 1981;7:355-360.
3. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery - survival data. Circulation. 1983;68:939-950.
4. Phibbs B, Fleming T, Ewy GA, et al. Frequency of normal coronary arteriograms in three academic medical centers and one community hospital. Am J Cardiol. 1988;62:472-474.
5. Geltman EM, Henes CG, Senneff MJ, Sobel BE, Bergmann SR. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol. 1990;16:586-595.
6. Botker HE, Sonne HS, Bagger JP, Nielsen TT. Impact of impaired coronary flow reserve and insulin resistance on myocardial energy metabolism in patients with syndrome X. Am J Cardiol. 1997;79:1615-1622.
7. Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141:735-741.
8. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
9. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
10. Schindler TH, Nitzsche EU, Schelbert HR, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol. 2005;45:1505-1512.
11. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027-1035.
12. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75-88.
13. Pasternak RC, Thibault GE, Savoia M, DeSanctis RW, Hutter AM Jr. Chest pain with angiographically insignificant coronary arterial obstruction: clinical presentation and long-term follow-up. Am J Med. 1980;68:813-817.
14. Rodriguez-Porcel M, Lerman A, Herrmann J, et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res. 2003;58:213-221.
15. Kozakova M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension: an integrated approach by transthoracic and transesophageal echocardiography. Hypertension. 1997;29:551-559.
16. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol. 2000;35:1654-1660.
17. Hamasaki S, Higano ST, Suwaidi JA, et al. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol. 2000;20:737-743.
18. Harrison DG, Marcus ML, Dellsperger KC, Lamping KG, Tomanek RJ. Pathophysiology of myocardial perfusion in hypertension. Circulation. 1991;83:III14-III18.
19. Czernin J, Barnard RJ, Sun KT, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 1995;92:197-204.
20. Czernin J, Sun K, Brunken R, Bottcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation. 1995;91:2891-2897.
21. Pitkanen OP, Raitakari OT, Niinikoski H, et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol. 1996;28:1705-1711.
22. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-817.
23. Strauer BE, Schwartzkopff B, Motz W, Vogt M. Coronary vascular changes in the progression and regression of hypertensive heart disease. J Cardiovasc Pharmacol. 1991;18(suppl 3):S20-S27.
24. Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274:894-901.
25. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function - long-term follow-up study. J Am Coll Cardiol. 1995;25:807-814.
26. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171-185.
27. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
28. Muzik O, Shen C, DiCarli M. IDL software package for absolute quantification of myocardial blood flow based on (N-13) ammonia PET data. Proceedings of the 25th Annual Meeting of Computers in Cardiology. Cleveland, OH: IEEE Computer Society Press. 1996;25:33-36.
29. Muzik O, Beanlands R, Wolfe E, Hutchins GD, Schwaiger M. Automated region definition for cardiac nitrogen-13-ammonia PET imaging. J Nucl Med. 1993;34:336-344.
30. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
31. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243-1250.
32. Graf S, Khorsand A, Gwechenberger M, et al. Myocardial perfusion in patients with typical chest pain and normal angiogram. Eur J Clin Invest. 2006;36:326-332.
33. Harrison DG, Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol. 1995;75:75B-81B.
34. Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation. 1998;98:1291-1296.
35. Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation. 1999;99:475-481.
36. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993;88:62-69.
37. Marcus ML, Harrison DG, Chilian WM, et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation. 1987;75:I19-I25.